OXIGENE (NASDAQ:OXGN)

View All ReportsStreetInsider.com Reports on OXGN

Nov 6, 2009 01:29 PM Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report

Oct 15, 2009 10:23 AM Notable Mergers and Acquisitions of the Day 10/15: PFE/WYE, VISN, OXGN

Oct 15, 2009 06:35 AM OXiGENE (OXGN) To Acquire VaxGen (VXGN) In Stock For Stock Deal

Oct 8, 2009 08:32 AM OXiGENE's (OXGN) CEO Kollins Regins; Langecker to Serve as Interim CEO

Jul 15, 2009 12:29 PM Unusual 11 Mid-Day Movers 7/15: TRGT, FOE, BEXP, GCI Higher; PAR, OXGN, UCBH, SSG Lower

View All Press ReleasesCompany Press Releases on OXGN

Nov 17, 2009 12:30PM OXiGENE Reports Positive Safety Data From Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2009 AACR-NCI-EORTC Conference

Nov 12, 2009 04:00PM OXiGENE to Present at American Society of Hematology and AACR/NCI/EORTC Meetings

Nov 10, 2009 02:00AM OXiGENE to Present at Merriman Curhan Ford and Lazard Healthcare Conferences

Nov 9, 2009 02:00AM OXiGENE Reports Third Quarter 2009 Financial Results

Nov 3, 2009 02:00AM OXiGENE Announces Third Quarter 2009 Earnings Conference Call and Webcast

StreetInsider Reports on OXGN by Category

• Analyst Ratings
• Mergers and Acquisitions
• Earnings
• Guidance
• Stock Buybacks
• Dividends
• Retail Sales
• Management Changes
• Insider Trades
• View More Categories

View All BlogsBlogs on OXGN

Oct 28, 2009 06:19 AM Interview: Greenbackd Sees Big Storm Clouds Everywhere

Aug 4, 2008 07:01 PM OxiGene, Inc. Q2 2008 Earnings Call Transcript

View All FilingsSEC Filings on OXGN

Nov 20, 2009 02:43PM Form 8-K OXIGENE INC For: Nov 17

Nov 10, 2009 03:38PM Form 10-Q OXIGENE INC For: Sep 30

Nov 9, 2009 08:54AM Form 8-K OXIGENE INC For: Nov 09

Nov 2, 2009 04:44PM Form 8-K/A OXIGENE INC For: Oct 08

Oct 16, 2009 05:30PM Form 8-K OXIGENE INC For: Oct 14

Comments on recent OXGN articles

mark
on Jun 1, 2009
at 02:22 PM Great money maker here! This stock is on the rise buy now
Article: OXiGENE (OXGN) Reports Positive Data From Investigator-Sponsored Phase 2 Study of ZYBRESTAT

DAVE
on Jun 1, 2009
at 02:18 PM BUY BUY BUY OXGN Buy Oxgn now while its low this stock will skyrocket vary soon the new drug comming on the market will make you lots of money
Article: OXiGENE (OXGN) Reports Positive Data From Investigator-Sponsored Phase 2 Study of ZYBRESTAT

Why
on Nov 14, 2008
at 09:37 PM Operate this idiot That isnt a tall what they say it is for. It doesnt take 50 million extra to monitor and pay for the trials at this late stage. Every penny you add to this flood of paper is going to be lost in dilution. There will be no gain whatsoever for the company and you know it. If they are that close to failure then stop paying management and the board so friggin much. There is a flood of medical and biotech equipment hitting the market as research companies fold. I saw Saigene auction 10 mil in equipment for 40K. WHy doesnt this company just finish what it started? How many more years of promises and how many fat lazy, non productive finance managers? One more mindless cheerleading response and I sell it all. If it has a hole in it I sell. You got that?
Article: Oxigene (OXGN) Files $50 Million Mixed-Securities Shelf

jimh
on Nov 14, 2008
at 05:06 PM operatinal money Actually, its the best time if you need to. Going forward it will only get harder and harder over the next two years to raise money. By raising enough money to stay operational for additional time this allows further progress of clinical stage items before signing a royalty agreement with a large pharma/biotech. The more good data comes out before signing an agreement means better terms and certainly will make up for any dilution from the better royalty rate.
Article: Oxigene (OXGN) Files $50 Million Mixed-Securities Shelf

Why
on Nov 14, 2008
at 03:25 PM Selling paper Not the time to sell any more paper. Are you just another wastefull bloated idiotic money pit with board members pocketing too much of the investors money? Do you have any more announcements? I will be waiting.
Article: Oxigene (OXGN) Files $50 Million Mixed-Securities Shelf

Comments on OXGN

No comments are currently available.

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?